These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12545804)

  • 1. [Recent progresses on the modulation of estrogen to dopaminergic neurons].
    Liu B; Xie JX
    Sheng Li Ke Xue Jin Zhan; 2001 Jul; 32(3):259-61. PubMed ID: 12545804
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
    Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dopaminergic neurons and clinical neuropsychiatry].
    Ferrari E
    Acta Neurol (Napoli); 1992; 14(4-6):241-64. PubMed ID: 1293968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and pathophysiology of dopaminergic neurons.
    Hornykiewicz O
    Adv Cytopharmacol; 1971 May; 1():369-77. PubMed ID: 4950404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Foxa2, a new player in the development of dopaminergic neurons in Parkinson disease].
    Epelbaum J
    Med Sci (Paris); 2008 Feb; 24(2):117. PubMed ID: 18272062
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxidative stress to dopaminergic neurons as models of Parkinson's disease.
    Gille G; Hung ST; Reichmann H; Rausch WD
    Ann N Y Acad Sci; 2004 Jun; 1018():533-40. PubMed ID: 15240412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors.
    Kipp M; Karakaya S; Pawlak J; Araujo-Wright G; Arnold S; Beyer C
    Front Neuroendocrinol; 2006 Dec; 27(4):376-90. PubMed ID: 16949139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonstriatal dopaminergic neurons: Section I. Mesocortical dopaminergic neurons: Introduction: mesocortical dopaminergic neurons.
    Axelrod J
    Adv Biochem Psychopharmacol; 1977; 16():1-3. PubMed ID: 883539
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic neurons.
    Chinta SJ; Andersen JK
    Int J Biochem Cell Biol; 2005 May; 37(5):942-6. PubMed ID: 15743669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.
    Sheldahl LC; Marriott LK; Bryant DM; Shapiro RA; Dorsa DM
    Minerva Endocrinol; 2007 Jun; 32(2):87-94. PubMed ID: 17557034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of estrogen and phytoestrogen on the dopaminergic systems of amygdala in rats].
    Dong XL; Xie JX
    Sheng Li Xue Bao; 2003 Oct; 55(5):589-93. PubMed ID: 14566409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin secretion as an index of brain dopaminergic function.
    Thorner MO; Login IS
    Adv Biochem Psychopharmacol; 1981; 28():503-20. PubMed ID: 6452035
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine and Parkinson's disease: is the killer in the house?
    Chesselet MF
    Mol Psychiatry; 2003 Apr; 8(4):369-70. PubMed ID: 12740592
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen stimulates galanin expression within luteinizing hormone-releasing hormone-immunoreactive (LHRH-i) neurons via estrogen receptor-beta (ERbeta) in the female rat brain.
    Merchenthaler I
    Neuropeptides; 2005 Jun; 39(3):341-3. PubMed ID: 15882902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulnerability to glutamate toxicity of dopaminergic neurons is dependent on endogenous dopamine and MAPK activation.
    Izumi Y; Yamamoto N; Matsuo T; Wakita S; Takeuchi H; Kume T; Katsuki H; Sawada H; Akaike A
    J Neurochem; 2009 Jul; 110(2):745-55. PubMed ID: 19457068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of the enzymes of dopamine synthesis in non-dopaminergic neurons: functional significance and regulation].
    Ugriumov MV
    Usp Fiziol Nauk; 2007; 38(4):3-20. PubMed ID: 18064905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology. miRNAs in neurodegeneration.
    Hébert SS; De Strooper B
    Science; 2007 Aug; 317(5842):1179-80. PubMed ID: 17761871
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine and adult neurogenesis.
    Borta A; Höglinger GU
    J Neurochem; 2007 Feb; 100(3):587-95. PubMed ID: 17101030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between environmental and genetic factors in the pathophysiology of Parkinson's disease.
    Tsang F; Soong TW
    IUBMB Life; 2003 Jun; 55(6):323-7. PubMed ID: 12938734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
    Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
    J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.